Qiagen N.V. (QGEN) — Analyst outlook / Analyst consensus target is. Based on 29 analyst ratings, the consensus is bullish — 12 Buy, 17 Hold.
The consensus price target is $54.33 (low: $50.00, high: $59.00), representing an upside of 30.1% from the current price $41.76.
Analysts estimate Earnings Per Share (EPS) of $2.34 and revenue of $1.98B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.37 vs est $2.34 (missed -84.2%). 2025: actual $2.04 vs est $2.39 (missed -14.8%). Analyst accuracy: 0%.
QGEN Stock — 12-Month Price Forecast
$54.33
▲ +30.10% Upside
Average Price Target
Based on 29 Wall Street analysts offering 12-month price targets for Qiagen N.V., the average price target is $54.33, with a high forecast of $59.00, and a low forecast of $50.00.
The average price target represents a +30.10% change from the last price of $41.76.
Highest Price Target
$59.00
Average Price Target
$54.33
Lowest Price Target
$50.00
QGEN Analyst Ratings
Hold
Based on 29 analysts giving stock ratings to Qiagen N.V. in the past 3 months
EPS Estimates — QGEN
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.37
vs Est $2.34
▼ 531.6% off
2025
Actual $2.04
vs Est $2.39
▼ 17.4% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is improving.
Revenue Estimates — QGEN
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $1.978B
vs Est $1.980B
▼ 0.1% off
2025
Actual $2.090B
vs Est $2.077B
▲ 0.6% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
